2-Chloro-6-methyl-4-(trifluoromethyl)pyridine

Catalog No. :
ACIEAG943
CAS No. :
22123-14-4
Molecular Formula :
C7H5ClF3N
Molecular Weight :
195.57

IUPAC Name:2-chloro-6-methyl-4-(trifluoromethyl)pyridine

2-Chloro-6-methyl-4-(trifluoromethyl)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g95%$117.00Login to see priceIn stockInquiry
100g95%$406.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Chloro-6-methyl-4-(trifluoromethyl)pyridine
IUPAC Name2-chloro-6-methyl-4-(trifluoromethyl)pyridine
MDL No.MFCD00052900
Molecular FormulaC7H5ClF3N
Molecular Weight195.57
SMILESCC1=CC(=CC(Cl)=N1)C(F)(F)F
InChI KeySXLBWNSGCIEART-UHFFFAOYSA-N
Synonym2-chloro-6-methyl-4-(trifluoromethyl)pyridine | 22123-14-4 | MFCD00052900 | Pyridine, 2-chloro-6-methyl-4-(trifluoromethyl)- | 2-chloro-6-methyl-4-trifluoromethylpyridine | 2-chloro-4-trifluoromethyl-6-methylpyridine | 2-chlor-6-methyl-4-(trifluormethyl)pyridine | 2-ch
CAS No.22123-14-4
PubChem CID2736626

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACIEAG943 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNFXH945 route compound structure diagram
    ACNFXH94539890-98-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIEAG943 route product structure diagram
    ACIEAG94322123-14-4 In Stock
Inquiry

2. ACIEAG943 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACONVX961 route compound structure diagram
    ACONVX961823221-94-9 In Stock
  4. Then
  5. ACIEAG943 route product structure diagram
    ACIEAG94322123-14-4 In Stock
Inquiry

Comments (0)